Skip to Main Content

Author Details

Wilfredo F Garcia-Beltran
Ragon Institute of MGH
2012
50
26
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37264229HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses.Nat Immunol2023
37252360Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2.ACS Cent Sci2023
37367252Blood group A enhances SARS-CoV-2 infection.Blood2023
35018386T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals.medRxiv2022
35587156Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19.Virulence2022
35665005Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins.bioRxiv2022
35364034T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.Cell2022
35749424HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells.PLoS Pathog2022
36423634Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design.Cell Rep Med2022
36136978Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins.Proc Natl Acad Sci U S A2022
34888672Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines.J Infect Dis2022
34995482mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.Cell2022
35202566T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.Cell2022
35232959Multi-modal profiling of human fetal liver hematopoietic stem cells reveals the molecular signature of engraftment.Nat Commun2022
33412089COVID-19-neutralizing antibodies predict disease severity and survival.Cell2021
33743213Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.Cell2021
33619506Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.medRxiv2021
33930298Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.Cell2021
34917099A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors.Front Immunol2021
34671780Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines.medRxiv2021
34122425Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection.Front Immunol2021
34265281Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.Cell2021
34260940HLA class-I-peptide stability mediates CD8<sup>+</sup> T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV.Cell Rep2021
33264390Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.Arch Pathol Lab Med2021
32511497Test performance evaluation of SARS-CoV-2 serological assays.medRxiv2020
33033172Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.Sci Immunol2020
33106822COVID-19 neutralizing antibodies predict disease severity and survival.medRxiv2020
33097667HLA tapasin independence: broader peptide repertoire and HIV control.Proc Natl Acad Sci U S A2020
32855547Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.Nat Biotechnol2020
31375574Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.J Virol2019
31358998A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44.Nat Immunol2019
30386333Stable Frequencies of HLA-C<sup>*</sup>03:04/Peptide-Binding KIR2DL2/3<sup>+</sup> Natural Killer Cells Following Vaccination.Front Immunol2018
30031767Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.Gastroenterology2018
27992415A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.Nat Genet2017
29184550Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.Front Immunol2017
28636952Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.Immunity2017
28546555Peptide-specific engagement of the activating NK cell receptor KIR2DS1.Sci Rep2017
27057987Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-Câ¿¿03:04 and modulate NK cell function.J Hepatol2016
27455421Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.Nat Immunol2016
27440904Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.J Virol2016
27466424Kinetics of HIV-1 Latency Reversal Quantified on the Single-Cell Level Using a Novel Flow-Based Technique.J Virol2016
27158667Innate immune reconstitution with suppression of HIV-1.JCI Insight2016
26680341Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01.PLoS One2015
26575988Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.PLoS Med2015
24785948Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function.AIDS2014
22688219Transgenic mouse model reveals an unsuspected role of the acetylcholine receptor in statin-induced neuromuscular adverse drug reactions.Pharmacogenomics J2013
23866914Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection.Retrovirology2013
23503923Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination.Adv Funct Mater2013
22084248Up-regulation of the neuronal nicotinic receptor α7 by HIV glycoprotein 120: potential implications for HIV-associated neurocognitive disorder.J Biol Chem2012
22697904Advancing medicine one research note at a time: the educational value in clinical case reports.BMC Res Notes2012
  • 1 - 50 of 50

Recommended Authors

Institute for Immunology, University of Pennsylvania Perelman School of Medicine
Career Start Year 2018
Number of shared co-authors 1
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 5
Yale University School of Medicine
Career Start Year 2017
Number of shared co-authors 1
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 8
Yale School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 2013
Number of shared co-authors 1
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 2013
Number of shared co-authors 1
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 1
Rockefeller University
Career Start Year 2011
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 2
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 2008
Number of shared co-authors 9
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 3
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 2005
Number of shared co-authors 2
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 3
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 0
University of California san francisco
Career Start Year 2002
Number of shared co-authors 16
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 2
The Rockefeller University
Career Start Year 2002
Number of shared co-authors 1
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 2002
Number of shared co-authors 4
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 20
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 2
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year 2000
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 8
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 4
Yale University
Career Start Year 1990
Number of shared co-authors 3
University of Georgia
Career Start Year 1989
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 4

Collaborators

Co-authored papers 18
Massachusetts General Hospital
Co-authored papers 17
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 14
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers 11
Ragon Institute of Mass General
Co-authored papers 9
Co-authored papers 6
Massachusetts General Hospital
Co-authored papers 6
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 5
Ragon Institute of MGH
Co-authored papers 4
Massachusetts General Hospital
Co-authored papers 4
University of California San Francisco
Co-authored papers 3
Keck School of Medicine, University of Southern California
Co-authored papers 3
The Robert Larner M.D. College of Medicine, University of Vermont
Co-authored papers 3
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 2
University of California-San Francisco
Co-authored papers 2
Allergy and Critical Care Medicine Emory University School of Medicine
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of Chicago
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
San Francisco General Hospital, University of California
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Co-authored papers 2
Division of Gastroenterology and Irvine Cancer Research Center, Columbia University
Co-authored papers 2
University of California san francisco
Co-authored papers 2